Autobio Diagnostics Co Ltd (603658) — Cash Flow-to-Debt Ratio
Autobio Diagnostics Co Ltd (603658) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥435.24 Million could theoretically repay 0% of its total liabilities (CN¥2.88 Billion) in one year. Check how aggressively does Autobio Diagnostics Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Autobio Diagnostics Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Autobio Diagnostics Co Ltd across 14 annual periods. Also explore 603658 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Autobio Diagnostics Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Autobio Diagnostics Co Ltd. For market capitalisation and broader financial context, see 603658 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.41x | CN¥1.31 Billion | CN¥3.18 Billion | ▼ -19.2% |
| 2023 | 0.51x | CN¥1.47 Billion | CN¥2.89 Billion | ▼ -16.4% |
| 2022 | 0.61x | CN¥1.56 Billion | CN¥2.56 Billion | ▼ -23.8% |
| 2021 | 0.80x | CN¥1.46 Billion | CN¥1.83 Billion | ▲ +24.6% |
| 2020 | 0.64x | CN¥994.71 Million | CN¥1.55 Billion | ▲ +23.4% |
| 2019 | 0.52x | CN¥842.89 Million | CN¥1.62 Billion | ▼ -45.1% |
| 2018 | 0.95x | CN¥653.73 Million | CN¥690.69 Million | ▼ -2.2% |
| 2017 | 0.97x | CN¥481.73 Million | CN¥497.85 Million | ▼ -58.9% |
| 2016 | 2.36x | CN¥415.82 Million | CN¥176.52 Million | ▲ +73.3% |
| 2015 | 1.36x | CN¥308.63 Million | CN¥227.01 Million | ▼ -20.1% |
| 2014 | 1.70x | CN¥256.93 Million | CN¥151.08 Million | ▲ +15.3% |
| 2013 | 1.47x | CN¥103.22 Million | CN¥70.00 Million | ▼ -1.3% |
| 2012 | 1.49x | CN¥69.32 Million | CN¥46.41 Million | ▲ +16.2% |
| 2011 | 1.29x | CN¥50.59 Million | CN¥39.36 Million | — |